期刊文献+

Value of glucose transport protein 1 expression in detecting lymph node metastasis in patients with colorectal cancer

在线阅读 下载PDF
导出
摘要 BACKGROUND There are limited data on the use of glucose transport protein 1(GLUT-1)expre-ssion as a biomarker for predicting lymph node metastasis in patients with colorectal cancer.GLUT-1 and GLUT-3,hexokinase(HK)-II,and hypoxia-induced factor(HIF)-1 expressions may be useful biomarkers for detecting primary tumors and lymph node metastasis when combined with fluorodeoxyglucose(FDG)uptake on positron emission tomography/computed tomography(PET/CT).AIM To evaluate GLUT-1,GLUT-3,HK-II,and HIF-1 expressions as biomarkers for detecting primary tumors and lymph node metastasis with 18F-FDG-PET/CT.METHODS This retrospective study included 169 patients with colorectal cancer who underwent colectomy and preoperative 18F-FDG-PET/CT at Chungbuk National University Hospital between January 2009 and May 2012.Two tissue cores from the central and peripheral areas of the tumors were obtained and were examined by a dedicated pathologist,and the expressions of GLUT-1,GLUT-3,HK-II,and HIF-1 were determined using immunohisto-chemical staining.We analyzed the correlations among their expressions,various clinicopathological factors,and the maximum standardized uptake value(SUVmax)of PET/CT.RESULTS GLUT-1 was found at the center or periphery of the tumors in 109(64.5%)of the 169 patients.GLUT-1 positivity was significantly correlated with the SUVmax of the primary tumor and lymph nodes,regardless of the biopsy site(tumor center,P<0.001 and P=0.012;tumor periphery,P=0.030 and P=0.010,respectively).GLUT-1 positivity and negativity were associated with higher and lower sensitivities of PET/CT,respectively,for the detection of lymph node metastasis,regardless of the biopsy site.GLUT3,HK-II,and HIF-1 expressions were not significantly correlated with the SUVmax of the primary tumor and lymph nodes.CONCLUSION GLUT-1 expression was significantly correlated with the SUVmax of 18F-FDG-PET/CT for primary tumors and lymph nodes.Clinicians should consider GLUT-1 expression in preoperative endoscopic biopsy in interpreting PET/CT findings.
出处 《World Journal of Clinical Cases》 SCIE 2024年第5期931-941,共11页 世界临床病例杂志
  • 相关文献

参考文献1

二级参考文献41

  • 1Yen TC,See LC,Lai CH,Tsai CS,Chao A,Hsueh S,Hong JH,Chang TC,Ng KK.Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.Eur J Nucl Med Mol Imaging2008;35:493-501.
  • 2Pessin JE,Bell GI.Mammalian facilitative glucose trans-porter family:structure and molecular regulation.Annu Rev Physiol1992;54:911-930.
  • 3Pardridge WM,Boado RJ,Farrell CR.Brain-type glucose transporter(GLUT-1)is selectively localized to the blood-brain barrier.Studies with quantitative western blotting and in situ hybridization.J Biol Chem1990;265:18035-18040.
  • 4Froehner SC,Davies A,Baldwin SA,Lienhard GE.The blood-nerve barrier is rich in glucose transporter.J Neurocy-tol1988;17:173-178.
  • 5Isselbacher KJ.Sugar and amino acid transport by cells in culture--differences between normal and malignant cells.N Engl J Med1972;286:929-933.
  • 6Sung JY,Kim GY,Lim SJ,Park YK,Kim YW.Expression of the GLUT1glucose transporter and p53in carcinomas of the pancreatobiliary tract.Pathol Res Pract2010;206:24-29.
  • 7Haber RS,Rathan A,Weiser KR,Pritsker A,Itzkowitz SH,Bodian C,Slater G,Weiss A,Burstein DE.GLUT1glucose transporter expression in colorectal carcinoma:a marker for poor prognosis.Cancer1998;83:34-40.
  • 8Abdel-Nabi H,Doerr RJ,Lamonica DM,Cronin VR,Galan-towicz PJ,Carbone GM,Spaulding MB.Staging of primary colorectal carcinomas with fluorine-18fluorodeoxyglucose whole-body PET:correlation with histopathologic and CT findings.Radiology1998;206:755-760.
  • 9Kostakoglu L,Goldsmith SJ.18F-FDG PET evaluation of the response to therapy for lymphoma and for breast,lung,and colorectal carcinoma.J Nucl Med2003;44:224-239.
  • 10Findlay M,Young H,Cunningham D,Iveson A,Cronin B,Hickish T,Pratt B,Husband J,Flower M,Ott R.Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases:correlation with tumor response to fluorouracil.J Clin Oncol1996;14:700-708.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部